Erratum

Corrigendum to “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool” (Contemporary Clinical Trials (2016) 50 (90–97)(S1551714416301331)(10.1016/j.cct.2016.07.013))

Li Tzy Wu, Jennifer McNeely, Geetha A. Subramaniam, Gaurav Sharma, Paul VanVeldhuisen, Robert P. Schwartz

Research output: Contribution to journalComment/debate

Abstract

In the article, we mistakenly stated that we drew select items from the World Health Organization's Composite International Diagnostic Interview 2.0 (WHO CIDI-2.0) substance abuse module to assess substance use disorders. However, we actually used select items from the WHO World Mental Health-CIDI [WMH-CIDI]: http://www.hcp.med.harvard.edu/wmhcidi/index.php). Additionally, the DSM-5 has only one set of criteria for all substance use disorders, including tobacco. Because the WMH-CIDI does not contain all the criteria for DSM-5 Tobacco Use Disorder, we adapted the language from the WMH-CIDI items from the drug section to assess tobacco use disorder. Readers of our article should note the mislabeling “modified CIDI-2” in Fig. 1 and on page 95. The correct description should read “modified WMH-CIDI.” The authors would like to apologise for any inconvenience caused.

Original languageEnglish (US)
Pages (from-to)98
Number of pages1
JournalContemporary Clinical Trials
Volume51
DOIs
StatePublished - Nov 1 2016
Externally publishedYes

Fingerprint

Validation Studies
Tobacco
Prescriptions
Mental Health
Alcohols
Clinical Trials
Substance-Related Disorders
Tobacco Use Disorder
Language
Interviews
corrigendum
Global Health
N-nitrosoiminodiacetic acid
tyrosyl-arginyl-phenylalanyl-sarcosine
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Erratum : Corrigendum to “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool” (Contemporary Clinical Trials (2016) 50 (90–97)(S1551714416301331)(10.1016/j.cct.2016.07.013)). / Wu, Li Tzy; McNeely, Jennifer; Subramaniam, Geetha A.; Sharma, Gaurav; VanVeldhuisen, Paul; Schwartz, Robert P.

In: Contemporary Clinical Trials, Vol. 51, 01.11.2016, p. 98.

Research output: Contribution to journalComment/debate

@article{3569851348034a518c41ff879c50bc11,
title = "Erratum: Corrigendum to “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool” (Contemporary Clinical Trials (2016) 50 (90–97)(S1551714416301331)(10.1016/j.cct.2016.07.013))",
abstract = "In the article, we mistakenly stated that we drew select items from the World Health Organization's Composite International Diagnostic Interview 2.0 (WHO CIDI-2.0) substance abuse module to assess substance use disorders. However, we actually used select items from the WHO World Mental Health-CIDI [WMH-CIDI]: http://www.hcp.med.harvard.edu/wmhcidi/index.php). Additionally, the DSM-5 has only one set of criteria for all substance use disorders, including tobacco. Because the WMH-CIDI does not contain all the criteria for DSM-5 Tobacco Use Disorder, we adapted the language from the WMH-CIDI items from the drug section to assess tobacco use disorder. Readers of our article should note the mislabeling “modified CIDI-2” in Fig. 1 and on page 95. The correct description should read “modified WMH-CIDI.” The authors would like to apologise for any inconvenience caused.",
author = "Wu, {Li Tzy} and Jennifer McNeely and Subramaniam, {Geetha A.} and Gaurav Sharma and Paul VanVeldhuisen and Schwartz, {Robert P.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.cct.2016.09.001",
language = "English (US)",
volume = "51",
pages = "98",
journal = "Contemporary Clinical Trials",
issn = "1551-7144",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Erratum

T2 - Corrigendum to “Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool” (Contemporary Clinical Trials (2016) 50 (90–97)(S1551714416301331)(10.1016/j.cct.2016.07.013))

AU - Wu, Li Tzy

AU - McNeely, Jennifer

AU - Subramaniam, Geetha A.

AU - Sharma, Gaurav

AU - VanVeldhuisen, Paul

AU - Schwartz, Robert P.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - In the article, we mistakenly stated that we drew select items from the World Health Organization's Composite International Diagnostic Interview 2.0 (WHO CIDI-2.0) substance abuse module to assess substance use disorders. However, we actually used select items from the WHO World Mental Health-CIDI [WMH-CIDI]: http://www.hcp.med.harvard.edu/wmhcidi/index.php). Additionally, the DSM-5 has only one set of criteria for all substance use disorders, including tobacco. Because the WMH-CIDI does not contain all the criteria for DSM-5 Tobacco Use Disorder, we adapted the language from the WMH-CIDI items from the drug section to assess tobacco use disorder. Readers of our article should note the mislabeling “modified CIDI-2” in Fig. 1 and on page 95. The correct description should read “modified WMH-CIDI.” The authors would like to apologise for any inconvenience caused.

AB - In the article, we mistakenly stated that we drew select items from the World Health Organization's Composite International Diagnostic Interview 2.0 (WHO CIDI-2.0) substance abuse module to assess substance use disorders. However, we actually used select items from the WHO World Mental Health-CIDI [WMH-CIDI]: http://www.hcp.med.harvard.edu/wmhcidi/index.php). Additionally, the DSM-5 has only one set of criteria for all substance use disorders, including tobacco. Because the WMH-CIDI does not contain all the criteria for DSM-5 Tobacco Use Disorder, we adapted the language from the WMH-CIDI items from the drug section to assess tobacco use disorder. Readers of our article should note the mislabeling “modified CIDI-2” in Fig. 1 and on page 95. The correct description should read “modified WMH-CIDI.” The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=84994721628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994721628&partnerID=8YFLogxK

U2 - 10.1016/j.cct.2016.09.001

DO - 10.1016/j.cct.2016.09.001

M3 - Comment/debate

VL - 51

SP - 98

JO - Contemporary Clinical Trials

JF - Contemporary Clinical Trials

SN - 1551-7144

ER -